Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In eukaryotic cells an uncleavable ubiquitin moiety conjugated to the N-terminus of a protein signals the degradation of the fusion protein via the proteasome-dependent ubiquitin fusion degradation (UFD) pathway. In yeast the molecular mechanism of the UFD pathway has been well characterized. Recently the human E3
ubiquitin-protein ligase
TRIP12 was connected with the UFD pathway, but little is otherwise known about this system in mammalian cells. In the present work, we utilized high-throughput imaging on cells transfected with a targeted siRNA library to identify components involved in degradation of the UFD substrate Ub(G76V)-YFP. The most significant hits from the screen were the E3 ubiquitin-protein ligase HUWE1, as well as PSMD7 and PSMD14 that encode proteasome subunits. Accordingly, knock down of
HUWE1
led to an increase in the steady state level and a retarded degradation of the UFD substrate. Knock down of
HUWE1
also led to a stabilization of the physiological UFD substrate UBB(+1). Precipitation experiments revealed that
HUWE1
is associated with both the Ub(G76V)-YFP substrate and the 26S proteasome, indicating that it functions late in the UFD pathway. Double knock down of
HUWE1
and TRIP12 resulted in an additive stabilization of the substrate, suggesting that
HUWE1
and TRIP12 function in parallel during UFD. However, even when both
HUWE1
and TRIP12 are downregulated, ubiquitylation of the UFD substrate was still apparent, revealing functional redundancy between
HUWE1
, TRIP12 and yet other ubiquitin-protein ligases.
...
PMID:HUWE1 and TRIP12 collaborate in degradation of ubiquitin-fusion proteins and misframed ubiquitin. 2320 76
Ehrlich and demethiolation pathways as two competing branches converted amino acid into alcohols. Controlling both pathways offers considerable potential for industrial applications including alcohols overproduction, flavor-quality control and developing new flavors. While how to regulate ehrlich and demethiolation pathways is still not applicable. Taking the conversion of methionine into methionol and methanethiol for example, we constructed two suppression subtractive cDNA libraries of Clonostachys rosea by using suppression subtractive hybridization (SSH) technology for screening regulators controlling the conversion. E3
ubiquitin-protein ligase
gene
HUWE1
screened from forward SSH library was validated to be related with the biosynthesis of end products. Overexpressing
HUWE1
in C. rosea and S. cerevisiae significantly increased the biosynthesis of methanethiol and its derivatives in demethiolation pathway, while suppressed the biosynthesis of methional and methionol in ehrlich pathway. These results attained the directional regulation of both pathways by overexpressing
HUWE1
. Thus,
HUWE1
has potential to be a key target for controlling and enhancing alcohols production by metabolic engineering.
...
PMID:Regulating ehrlich and demethiolation pathways for alcohols production by the expression of ubiquitin-protein ligase gene HUWE1. 2686 Aug 95
E3
ubiquitin-protein ligase
(
HUWE1
) has previously been identified as a HECT domain-containing ubiquitin ligase (E3) that is involved in several signaling pathways, transcriptional regulation, neural differentiation, DNA damage responses and apoptosis. However, the function of
HUWE1
in the various types of cancer remains unclear. A previous study indicated that
HUWE1
exhibited different roles depending on the cancer type due to the ubiquitination of various substrates. The objective of the present study was to determine whether
HUWE1
can be employed as a prognostic indicator in human cancer. The expression of
HUWE1
was examined using the Oncomine database, and gene alterations during carcinogenesis, copy number alterations and mutations of
HUWE1
were then analyzed using cBioPortal, which is the International Cancer Genome Consortium and the Tumorscape database. Furthermore, the association between
HUWE1
expression and patient survival was evaluated using Kaplan-Meier plotter and the PrognoScan databases. In addition, the present study attempted to establish the functional association between
HUWE1
expression and cancer phenotypes, and the results revealed that
HUWE1
may serve as a diagnostic marker or therapeutic target for certain types of cancer.
HUWE1
may serve an oncogenic role in breast, brain and prostate cancer, while it may serve an anti-oncogenic role in colorectal cancer and certain lung cancers. The function of
HUWE1
and its mechanisms require more in-depth and extensive investigation in future studies.
...
PMID:Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer. 3140 87